Phantom Neuro
The CYBORG study will evaluate the company's muscle-machine interface, which uses an implantable sensor array in an amputee's residual limb to enable real-time, intuitive control of prosthetic limbs and robotic systems.
Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.
The company's minimally invasive muscle-machine interface, Phantom X, allows one to control prosthetic limbs and robotic exoskeletons as extensions of the human body.